NOX1/NADPH oxidase is involved in the LPS-induced exacerbation of collagen-induced arthritis.
Arthritis
Endotoxin
LPS
NADPH oxidase
Reactive oxygen species
Journal
Journal of pharmacological sciences
ISSN: 1347-8648
Titre abrégé: J Pharmacol Sci
Pays: Japan
ID NLM: 101167001
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
02
10
2020
revised:
19
01
2021
accepted:
25
01
2021
entrez:
4
5
2021
pubmed:
5
5
2021
medline:
21
10
2021
Statut:
ppublish
Résumé
We investigate as yet an unidentified role of NOX1, a non-phagocytic isoform of the superoxide-generating NADPH oxidase, in immune responses using Nox1-knockout mice (Nox1-KO). The transcripts of NOX1 was expressed in lymphoid tissues, including the spleen, thymus, bone marrow, and inguinal lymphoid nodes. When antibody production after ovalbumin (OVA) immunization was examined, no significant differences were observed in serum anti-OVA IgG levels between wild-type mice (WT) and Nox1-KO. In the experimental asthma, the infiltration of eosinophils and the Th2 cytokine response after the induction of asthma with OVA were similar between the two genotypes. However, the severity and incidence of experimental collagen-induced arthritis (CIA) following the administration of a low dose of endotoxin (LPS) were significantly lower in Nox1-KO. While neither serum levels of autoantibodies nor in vitro cytokine responses were affected by Nox1 deficiency, NOX1 mRNA levels in the spleen significantly increased after the LPS challenge. Among the spleen cells, remarkable LPS-induced upregulation of NOX1 was demonstrated in both CD11b
Identifiants
pubmed: 33941325
pii: S1347-8613(21)00010-4
doi: 10.1016/j.jphs.2021.01.009
pii:
doi:
Substances chimiques
Endotoxins
0
RNA, Messenger
0
Collagen
9007-34-5
NADPH Oxidase 1
EC 1.6.3.-
NOX1 protein, mouse
EC 1.6.3.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
88-97Informations de copyright
Copyright © 2021 The Authors. Production and hosting by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest C. Y.-N. is the cofounder of a startup company developing NOX inhibitors.